Telledant LLC

On April 18, 2013, an ad review letter was sent to the company based on questionable claims displayed on their website www.biogetica.com. Our concerns with their product advertising are that the clinical trials published on their site are old and outdated, have non working links. Others are studies performed in foreign countries that would be difficult to verify, or some were performed only on mice.

The following claims are taken directly from the company's website:

• Arthritis - Plant-based formulations provide a unique modality of treatment of rheumatoid arthritis as they are safe and have a disease-modifying action. Arthrella tablets can be used for reducing the pain and inflammation of rheumatoid arthritis.

• Obesity - The patients with Tablet Obenyl showed 84.33% result while patients on placebo therapy showed 13.33% response.

• Eczema - Ingredients showed positive results in 88% of Eczema patients

• Depression - We thus hereby conclude, that Tablet Sumenta has shown significant anti-depressant activity in mild to moderate cases of depression and is recommended as a first line therapy in these patients

• Infertility - Addyzoa is effective in improving the semen quality by increasing the sperm count and sperm motility.

We asked the company to provide us with substantiations that the advertised clinical trials and medicinal claims could be backed up by adequate documentation. To date we have not received a response.